• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Nano Chemical Systems Holdings (NCSH) Completes Name Change to PanGenex Corporation (PGXC)

Posted on: Monday, 7 April 2008, 15:00 CDT

PanGenex Corporation (Pink Sheets:PGXC) (formerly Pink Sheets:NCSH) announces that on February 21st, 2008, its Board of Directors approved a 1-for-17 reverse split of its outstanding common stock. The company has changed its name to PanGenex Corporation to reflect its entry into the nutraceutical and cardiovascular health industries.

The number of shares of the Company's outstanding common stock will be reduced to approximately 5.9 million shares, including an approximate float of 1 million shares as a result of the split.

Jeff Roman, President and CEO of PanGenex, stated, "We are very excited to have executed the initial step of our business model. Recent findings published in the New England Journal of Medicine, from studies conducted at the University of California and around the US, found that 'measuring calcium deposits in the arteries of the heart is a good predictor of future heart disease'. Our team is confident that finalizing the acquisition of Calgenex Corporation is the best strategic move for our organization and our shareholders."

Calgenex is one of the only companies in the world that develops and markets proprietary formulations to address specific health conditions. Calgenex has developed a line of nutraceutical products addressing soft tissue calcification and cholesterol as well as over the counter drug products for psoriasis, eczema and dermatitis.

Over the coming weeks PanGenex will be releasing information regarding:

Status of the filing of the Company's Disclosure Statement on PinkSheets.com and status as a fully-reporting public entity

Information regarding the acquisition of Calgenex Corporation

Continued growth and progress within the dietary supplement and health marketplace

The formation of the Board of Directors and Scientific Advisory Board

Business progress including revenues, product lines and projections

About PanGenex Corporation:

PanGenex is a publicly traded company (PINK SHEETS: PGXC) and pursues business opportunities in the nutraceutical and cardiovascular health industries. The Company seeks to develop and market novel, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Learn more about PanGenex Corporation at www.PanGenex.com.

Learn more about Calgenex Corporation by visiting: www.Calgenex.com.

Disclaimer:

Cautionary Statement about Forward-Looking Statements

This press release contains "forward-looking statements," which are statements related to future, not past, events. In this context, the forward-looking statements often include statements regarding our goals, plans, projections and guidance regarding our financial position, results of operations, market position, pending and potential future acquisitions and business strategy, and often contain words such as "expects,""anticipates,""intends,""plans,""believes,""seeks" or "will." Any such forward-looking statements are not assurances of future performance and involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. These risks and uncertainties include, among other things, (a) general economic and business conditions, (b) the level of strategic partner incentives, (c) the future regulatory environment, (d) our cost of financing, (e) our ability to complete acquisitions and dispositions and the risks associated therewith, and (f) our ability to retain key personnel. These factors, as well as additional factors, could affect our forward-looking statements. We urge you to carefully consider this information. We undertake no duty to update our forward-looking statements, including our earnings outlook.

Source: Business Wire

More News in this Category